Benefits–Not Just Costs–of Medicines Must Be a Part of Discussion
According to Dr. Robert W. Dubois, Interim President and CEO of NPC, in the context of healthcare costs, the amount [...]
New Study Examines Perspective and Costing in Cost-Effectiveness Analysis
A recent study examined perspective and costing approaches used in cost-effectiveness analyses (CEAs) and the distribution of reported incremental cost-effectiveness [...]
Balancing Research Needs and Big Data Security in Europe
Optimal allocation of limited resources depends upon development of sound evidence demonstrating ‘value for money’ and is thus a critical [...]
HTA in the USA: ICER vs NICE
The Institute for Clinical and Economic Review (ICER) has a reputation for performing high-quality independent health technology assessments (HTAs) in [...]
Big Pharma’s Stealthy Efforts to Undermine ICER
The Institute for Clinical and Economic Review (ICER) wields considerable influence over drug prices by providing analysis of a medicine’s [...]
World’s Most Expensive Prescription Drug Shows Promise in Trial
Episalvan, an orphan drug for a condition called epidermolysis bullosa, is an EMA-approved drug for partial thickness wounds. Shortly after [...]
Applying Adult Learning Principles to Virtual Delivery of Medical Education
Medical education is just one of the many fields radically altered by the COVID-19 pandemic. Medical conferences were either canceled [...]
[Webinar] RWE’s moment: What COVID-19 means for you
The desire for new insights is driving the need for real-world evidence (RWE) across our industry. Join the latest Reuters [...]
New Survey Aims to Find Solutions to Most Pressing Pandemic Challenges
COVID-19 has drastically changed the healthcare landscape, leaving many in crisis mode wondering how to best handle this new reality. [...]
CMS Streamlines Compare Websites With New Care Compare Website
The Centers for Medicare & Medicaid Services (CMS) officially launched Care Compare, a patient-facing website streamlining all CMS Compare websites [...]
Generics Form Essential Bridge to COVID-19 Vaccine
Dan Leonard, the newly named CEO of the Association for Accessible Medicines, believes that generic and biosimilar medicines are an [...]
Addressing Health Inequities Through Traditional Value Frameworks
Join Jason Shafrin, Vice President of Health Economics, and Meena Venkatachalam, Senior Director of Health Economics at PRECISIONheor as they [...]
Clinical Trial Design from a Program Perspective
Join Cytel’s co-founder, Nitin Patel, as he discusses the value in designing clinical trials from a program-level perspective. This webinar [...]
2021 Sternfels Prize Contest Now Open
The $35,000 cash is awarded to the most novel, clinically relevant, and testable ideas in research that aim to reduce [...]
[Webinar] Getting Started With Real World Evidence
Real world evidence (RWE) is becoming increasingly important for stakeholders as they make decisions across product lifecycles. IQVIA has made [...]
Are Virtual Medical Conferences The New Normal?
Thanks to COVID-19, the gradual trend toward virtual platforms has rushed forward at breakneck speed, resulting in a diverse array [...]
Prof. Thomas Rice on Shifting Behavior to Flatten the Curve
In an interview with ISPOR, distinguished professor of the Department of Health Policy and Management at UCLA, Thomas Rice, talks [...]
Jens Gruger Outlines Vision For ISPOR
Jens Gruger assumed the role of President of ISPOR writing: "I have assumed my role as President of ISPOR at [...]
Improving National Clinical Datasets for Health Equity Research
In spite of focused clinical, research, and policy efforts, great disparities in healthcare and outcomes persist. According to researchers, the [...]
No Need for Trump to Eliminate Rebates
In July, the Trump administration announced its intention to eliminate rebates for Medicare Part D drugs to lower prescription drug [...]
[Webinar] 5 Years of ICER – Insights and Impact on Payers
Payers are increasingly reliant on ICER reports for their formulary decision making process. Join this webinar on Tuesday, September 15, [...]
Regulators Need to Plan Now For Allocating COVID-19 Vaccine
Not enough attention is being paid to how exactly a COVID-19 vaccine will be rolled out. What will happen after [...]
Non-submissions to NICE on the Rise Much to the Chagrin of the NHS
The National Institute for Health and Care Excellence’s (NICE) treatment appraisal is a voluntary process. If companies opt not to [...]
Emmy Award-winning Journalist, Epidemiologist, Author and Physician Seema Yasmin Slated to Give ISMPP West 2020 Keynote Address on October 1
Dr. Yasmin received her medical degree from the University of Cambridge and her journalism degree from the University of Toronto. [...]
With Dr. Robert Dubois at the Helm, the National Pharmaceutical Council (NPC) Solidifies Commitment to High-Quality Patient-Centered Research and Evidence-based Dialogue
Dr. Robert Dubois, the newly appointed interim president and CEO of NPC, outlined his vision for the organization during his [...]